ReviewDermatology and therapy2022

A Review of Phase 3 Trials of Dupilumab for the Treatment of Atopic Dermatitis in Adults, Adolescents, and Children Aged 6 and Up.

Jennifer Cather et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.